Thrombolysis or primary angioplasty? Reperfusion therapy for myocardial infarction in the UK

Area of Science:

• Cardiology
• Health Economics
• Healthcare Management

Background:

• Acute myocardial infarction (AMI) management involves reperfusion strategies like intravenous thrombolysis and percutaneous coronary intervention (PCI).
• Growing evidence suggests primary PCI offers superior long-term outcomes for AMI compared to thrombolysis.
• Existing research is primarily from US/European healthcare systems, questioning direct applicability to the UK's National Health Service (NHS).

Purpose of the Study:

• To evaluate the evidence base for primary PCI in treating AMI.
• To discuss the implications of widespread primary PCI adoption within the NHS.
• To explore early (pre-hospital) thrombolysis as a potentially cost-effective alternative to PCI in the NHS setting.

Main Methods:

• Review of recent trials and meta-analyses on primary PCI versus thrombolysis for AMI.
• Analysis of healthcare system differences between US/Europe and the UK.
• Consideration of economic factors and patient outcomes for different reperfusion strategies.

Main Results:

• Primary PCI demonstrates better long-term patient outcomes in AMI treatment.
• Widespread implementation of primary PCI poses significant organizational challenges for the NHS.
• Early pre-hospital thrombolysis presents a potential alternative with comparable outcomes and reduced costs.

Conclusions:

• The effectiveness and cost-effectiveness of primary PCI versus early thrombolysis require careful consideration within the NHS.
• Adapting international findings to the specific context of the NHS is crucial for optimal AMI management.
• Balancing patient benefit with economic viability is paramount for healthcare interventions in the current financial climate.